Jama Ophthalmology
Overview
JAMA Ophthalmology is a prestigious peer-reviewed medical journal that focuses on advancements in the field of ophthalmology. It publishes high-quality research articles, clinical studies, and reviews, covering a wide range of topics including eye diseases, surgical techniques, diagnostic tools, and innovative therapies. With its rigorous editorial process and commitment to disseminating cutting-edge knowledge, JAMA Ophthalmology serves as a valuable resource for ophthalmologists, researchers, and healthcare professionals worldwide.
Details
Details
Abbr.
JAMA Ophthalmol
Publisher
American Medical Association
Start
2013
End
Continuing
Frequency
Monthly
p-ISSN
2168-6165
e-ISSN
2168-6173
Country
United States
Language
English
Specialty
Ophthalmology
Metrics
Metrics
h-index / Ranks: 534
221
SJR / Ranks: 800
2553
CiteScore / Ranks: 901
12.30
JIF / Ranks: 667
8.1
Recent Articles
1.
Liu S, Sadan A, Bhattacharyya N, Zarouchlioti C, Szabo A, Abreu Costa M, et al.
JAMA Ophthalmol
. 2025 Mar;
PMID: 40079965
Importance: Understanding the pathogenic mechanisms of Fuchs endothelial corneal dystrophy (FECD) could contribute to developing gene-targeted therapies. Objective: To investigate associations between demographic data and age at first keratoplasty in...
2.
3.
4.
Khanani A, Campochiaro P, Graff J, Marcus D, Miller D, Mittra R, et al.
JAMA Ophthalmol
. 2025 Mar;
PMID: 40048197
Importance: Frequent visits and intravitreal anti-vascular endothelial growth factor (VEGF) injections are often required to manage diabetic macular edema (DME), burdening patients and their health care networks. The Port Delivery...
5.
Warner D, Jeng B, Kim J, Liu M, Troxel A, Hochman J, et al.
JAMA Ophthalmol
. 2025 Mar;
PMID: 40048191
Importance: Evidence regarding suppressive valacyclovir treatment on postherpetic neuralgia is necessary to guide care. Objective: To test the hypothesis that suppressive treatment with 1000 mg/d of oral valacyclovir for 12...
6.
Cohen E, Troxel A, Liu M, Hochman J, Baratz K, Mian S, et al.
JAMA Ophthalmol
. 2025 Mar;
PMID: 40048183
Importance: High-quality evidence regarding suppressive valacyclovir treatment in herpes zoster ophthalmicus (HZO) is necessary to guide care. Objective: To determine whether suppressive valacyclovir compared with placebo delays the occurrence of...
7.
8.
9.
Pieramici D, Awh C, Chang M, Emanuelli A, Holekamp N, Hu A, et al.
JAMA Ophthalmol
. 2025 Mar;
PMID: 40048178
Importance: Frequent prophylactic intravitreal anti-vascular endothelial growth factor injections can reduce risk of progression to vision-threatening complications in nonproliferative diabetic retinopathy (NPDR). A refillable drug delivery system for continuous intraocular...
10.